US30050B1017 - Common Stock
Top movers in Friday's session
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Get insights into the top gainers and losers of Friday's pre-market session.
EVH earnings call for the period ending September 30, 2024.
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Revenue of $621.4 million, an increase of $110.4 million or 21.6%, from the three months ended September 30, 2023. Net loss attributable to common shareholders...
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
Evolent Health Inc.’s shares jumped after a report that the company is in talks with private equity firms for a potential sale.
EVH earnings call for the period ending June 30, 2024.
EVH stock results show that Evolent Health beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
Top tech stocks have the potential to supercharge your portfolio. The question is, which ones do you pick out of the crowded field?
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
/PRNewswire/ -- Evolent Health, Inc. ("Evolent" or "the Company"), (NYSE: EVH) a company focused on achieving better health outcomes for people with complex...
EVH earnings call for the period ending March 31, 2024.
EVH stock results show that Evolent Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evolent Health (NYSE:EVH) just reported results for the first quarter of 2024.E...
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a $2 billion revenue company focused on achieving better health outcomes for people with complex conditions,...